Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01228305 · ClinicalTrials.gov registry record · NA
Acetaminophen for Oxidative Stress After Cardiopulmonary Bypass
A NA study of Congenital Heart Disease and Cardiopulmonary Bypass, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT01228305 is a NA study of Congenital Heart Disease and Cardiopulmonary Bypass that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 30 participants, below the 474-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01228305, a NA study of Congenital Heart Disease and Cardiopulmonary Bypass, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The current proposal tests the central hypothesis that acetaminophen will attenuate the oxidative stress response associated with cardiopulmonary bypass (CPB)-induced hemolysis in children undergoing cardiac surgery.
Conditions Studied
Interventions
- OTHER Acetaminophen
Study Locations (1)
Tennessee
- Vanderbilt University - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2011-07 |
| Est. Completion | 2014-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01228305
The ClinicalTrials.gov registry entry for NCT01228305 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 474-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (94% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Congenital Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which Acetaminophen is the first listed.
NCT01228305 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT01228305 about?
NCT01228305 is a clinical study titled "Acetaminophen for Oxidative Stress After Cardiopulmonary Bypass". The current proposal tests the central hypothesis that acetaminophen will attenuate the oxidative stress response associated with cardiopulmonary bypass (CPB)-induced hemolysis in children undergoing cardiac surgery.
What is the current status of trial NCT01228305?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2011-07. Estimated completion is 2014-03.
What conditions does trial NCT01228305 study?
This clinical trial studies the following conditions: Congenital Heart Disease, Cardiopulmonary Bypass.
What interventions are being tested in trial NCT01228305?
The interventions under investigation include: Acetaminophen (OTHER).
Who is sponsoring clinical trial NCT01228305?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01228305 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fontan Fitness Trial
RECRUITING · NA
-
Blood Conservation in Patients (3.5-12kg) Undergoing Congenital Cardiac Surgery
RECRUITING · NA
-
The Sequencing for Detection in Congenital Heart Disease (SD-CHD) Study
RECRUITING · NA
-
Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study
RECRUITING · NA
-
A Study of Hemodynamic Cardiopulmonary Exercise for CHD
RECRUITING · NA
-
Ventripoint Single Ventricle Study
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.